CT
CRL icon

Clearstead Trust’s Charles River Laboratories CRL Stock Holding History

Clearstead Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59K Sell
7
-11
-61% -$1.96K ﹤0.01% 907
2026
Q1 		$3.1K Buy
+18
New +$3.34K ﹤0.01% 833
2025
Q4 		– Sell
-9
Closed -$1.41K – 1127
2025
Q3 		$1.41K Hold
9
– – ﹤0.01% 1111
2025
Q2 		$1.37K Buy
+9
New +$1.2K ﹤0.01% 1060

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Clearstead Trust's CRL Position: Q2 2026 in Review

Clearstead Trust reduced its Charles River Laboratories (CRL) stake by 61% in Q2 2026, selling an estimated $1.96K and leaving 7 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

Clearstead Trust first reported a position in CRL in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.1K in Q1 2026. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Clearstead Trust held 7 shares of Charles River Laboratories worth $1.59K as of Q2 2026.
  • Clearstead Trust sold 11 Charles River Laboratories shares in Q2 2026, an estimated $1.96K.
  • Charles River Laboratories made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #907 holding.
  • Clearstead Trust first reported a position in Charles River Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Clearstead Trust's Charles River Laboratories position peaked at $3.1K in Q1 2026.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.